SCHEMBL19998749

SCHEMBL19998749

Cc1cc(C)cc(-c2ccc(-n3c4ccc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)cc4c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc43)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
ATM Q13315 1/20 0.53
AKR1C4 P17516 1/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
PTGER4 P35408 1/20 0.41
TSPO P30536 1/20 0.40
HDAC4 P56524 1/20 0.40
ALDH1A1 P00352 5/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
HSD17B10 Q99714 3/20 0.36
TSHR P16473 2/20 0.36
POLB P06746 1/20 0.36
BRCA1 P38398 1/20 0.36
AVPR1A P37288 1/20 0.36
RXFP1 Q9HBX9 2/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19998724 1.00 KDM4E (0.53) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998748 1.00 KDM4E (0.53) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998789 1.00 KDM4E (0.53) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998746 1.00 KDM4E (0.53) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998780 1.00 KDM4E (0.53) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998728 0.97 L3MBTL1 (0.50) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998726 0.97 L3MBTL1 (0.50) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL20152247 0.97 KDM4E (0.47) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL10130363 0.97 KDM4E (0.56) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998882 0.96 L3MBTL1 (0.49) KDM4EL3MBTL1ATMAKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD (JP) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC18A1, SLC1A2, SLC43A1 KDM4E 1587/4885L3MBTL1 1552/4885ATM 3732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.